Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

FDA Concerns Are the Least of These Drugs' Worries
Motley Fool
Mon, 03/17/14 - 09:53 am
Tags:
FDA, PCSK9 inhibitors, Regeneron, Sanofi, Merck, alirocumab
Health-Care Stocks: Growing Like Gangbusters
Motley Fool
Sat, 03/15/14 - 10:06 am
Tags:
Regeneron, Sanofi, Gilead Sciences, Celgene, Allergan
With FDA Concerns Public, What's Next for These Cholesterol Drugs?
Motley Fool
Thu, 03/13/14 - 05:55 pm
Tags:
FDA, Regeneron, Pfizer, Amgen, PCSK9 inhibitors
FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade
Forbes
Sat, 03/8/14 - 10:31 am
Tags:
PCSK9 inhibitors, Regeneron, Sanofi, hypercholesterolemia
FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
Yahoo/Reuters
Fri, 03/7/14 - 03:55 pm
Tags:
Sanofi, FDA, Regeneron, alirocumab, PCSK9 inhibitors
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
Tags:
InterMune, Esbriet, Alexion, Soliris, Vivus, Qsymia, Regeneron, Eylea
Regeneron Chief Leonard Schleifer Becomes A Billionaire After 25 Year Search For New Drugs
Forbes
Wed, 02/26/14 - 11:04 am
Tags:
Regeneron, Leonard Schleifer, executive pay
One Reason the Biotech Boom Won’t Turn to Bust
Barron's
Tue, 02/25/14 - 11:17 am
Tags:
biotech, Biogen Idec, Regeneron
No Looking Back for Regeneron's Eylea
Yahoo/Zacks.com
Tue, 02/25/14 - 11:05 am
Tags:
Regeneron, Eylea, BRVO
Biotech: Too Big for Its Britches?
Barron's
Mon, 02/24/14 - 05:05 pm
Tags:
biotech, Celgene, Gilead Sciences, Biogen Idec, Amgen, Regeneron
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Yahoo/Zacks.com
Wed, 02/19/14 - 09:26 am
Tags:
Regeneron, Eylea, Gilead Sciences, ledipasvir, Sovaldi, hepatitis C, Cangrelor, The Medicines Company
Breakout Week for Biotech? Comment Now Follow Comments
Forbes
Tue, 02/11/14 - 10:37 am
Tags:
Seattle Genetics, Regeneron
Why Regeneron Pharmaceuticals Has A Bright Future Ahead
Seeking Alpha
Tue, 02/11/14 - 08:52 am
Tags:
Regeneron, Arcalyst, Eylea, Zaltrap
Is There Investment Upside In The Future Of Treating Diabetes?
Seeking Alpha
Mon, 02/10/14 - 08:43 am
Tags:
diabetes, MannKind, Merck, Novo Nordisk, NeoStem, Regeneron
Can Biotech Dominate for a 4th Year in a Row?
Motley Fool
Mon, 02/3/14 - 09:35 am
Tags:
biotech, IPOs, Amgen, Ariad Pharmaceuticals, Regeneron
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal
Yahoo/Zacks.com
Wed, 01/22/14 - 04:14 pm
Tags:
Sarepta Therapeutics, Alnylam, Jazz Pharmaceuticals, Regeneron, Celgene
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
Seeking Alpha
Tue, 01/21/14 - 08:14 am
Tags:
earnings, United Therapeutics, Celgene, Regeneron, Biogen Idec, Acorda Therapeutics, Amgen, Gilead Sciences
Illumina, Regeneron, Intuitive Q4 Results Impress
Investors.com
Wed, 01/15/14 - 08:58 am
Tags:
earnings, Illumina, Regeneron, Intuitive Surgical
Three biopharma companies poised for product OKs in 2014: analyst
Marketwatch
Mon, 01/6/14 - 04:34 pm
Tags:
Cubist, Regeneron, Spectrum
Semantics 101: Goldman’s Biotech Downgrade and the New Biotech Consensus
Barron's
Mon, 01/6/14 - 11:44 am
Tags:
biotech, Amgen, Regeneron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.